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Abstract
Introduction:	The	neuronal	ceroid	lipofuscinoses	(NCLs;	Batten	disease)	are	a	group	
of fatal neurodegenerative lysosomal storage diseases of children caused by various 
mutations	in	a	range	of	genes.	Forms	associated	with	mutations	in	two	of	these,	CLN5 
and CLN6, are being investigated in well‐established sheep models. Brain atrophy 
leading	to	psychomotor	degeneration	is	among	the	defining	features,	as	is	regional	
progressive ossification of the inner cranium. Ongoing viral‐mediated gene therapy 
trials in these sheep are yielding encouraging results. In vivo assessment of brain at‐
rophy is integral to the longitudinal monitoring of individual animals and provides 
robust data for translation to treatments for humans.
Methods:	 Computed	 tomography	 (CT)‐based	 three‐dimensional	 reconstruction	 of	
the	intracranial	volume	(ICV)	over	time	reflects	the	progression	of	cortical	brain	atro‐
phy,	verifying	the	use	of	ICV	measurements	as	a	surrogate	measure	for	brain	size	in	
ovine	NCL.
Results:	ICVs	of	NCL‐affected	sheep	increase	for	the	first	few	months,	but	then	de‐
cline progressively between 5 and 13 months in CLN5−/− sheep and 11–15 months in 
CLN6−/− sheep. Cerebral ventricular volumes are also increased in affected animals. 
To	facilitate	ICV	measures,	the	radiodensities	of	ovine	brain	tissue	and	cerebrospinal	
fluid	were	identified.	Ovine	brain	tissue	exhibited	a	Hounsfield	unit	(HU)	range	of	(24;	
56)	and	cerebrospinal	fluid	a	HU	range	of	(−12;	23).
Conclusions: Computed tomography scanning and reconstruction verify that brain atro‐
phy	 ovine	 CLN5	NCL	 originates	 in	 the	 occipital	 lobes	 with	 subsequent	 propagation	
throughout	the	whole	cortex	and	these	regional	differences	are	reflected	in	the	ICV	loss.
K E Y W O R D S
3D	reconstruction,	Batten	disease,	brain,	cranial	ossification,	CT,	Hounsfield	units,	in	vivo,	
longitudinal	monitoring,	NCL,	neurodegeneration,	neuroimaging,	neuronal	ceroid	
lipofuscinoses,	radio‐density
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1  | INTRODUC TION
The	 neuronal	 ceroid	 lipofuscinoses	 (NCLs,	 Batten	 disease)	 are	 a	
group of mainly autosomal recessively inherited lysosomal stor‐
age diseases caused by mutations in a number of genes that lead 
to	 degenerative	 and	 fatal	 encephalopathies	 in	 children	 (Haltia,	
2006).	Affected	 children	progressively	develop	blindness,	motor	
degeneration,	 epilepsy,	 and	 dementia,	 eventually	 reaching	 total	
dependency	 and	 premature	 death	 (Kousi,	 Lehesjoki,	 &	 Mole,	
2012;	Mole,	Williams,	 &	 Goebel,	 2005,	 2011).	 There	 are	 no	 ef‐
fective	treatments.	The	NCLs	are	unified	through	severe	cerebral	
neurodegeneration,	 neuroinflammation,	 and	 the	 nearly	 ubiqui‐
tous intracellular accumulation of storage bodies containing spe‐
cific	proteins	(Kousi	et	al.,	2012;	Mole,	Williams,	&	Goebel,	2005;	
Palmer,	2015;	Palmer	et	al.,	2015).	A	flock	of	sheep	with	a	muta‐
tion in the CLN5 gene and two with mutations in the CLN6 gene 
provide well‐established large animal models that largely mirror 
the human pathological changes including the intracellular accu‐
mulation	of	subunit	c	of	the	mitochondrial	ATP	synthase	(Cook	et	
al.,	2002;	Frugier	et	al.,	2008;	Jolly	et	al.,	1989;	Jolly,	Arthur,	Kay,	
&	 Palmer,	 2002;	 Palmer,	 2015).	 Other	 common	 features	 of	 the	
ovine	and	human	NCLs	include	progressive	cerebral	atrophy	and	
enlargement	of	the	cerebral	ventricles	 (Frugier	et	al.,	2008;	Jolly	
et	al.,	2002,	1989	;	Woods	et	al.,	1993).	Neuroimaging	techniques,	
such	as	magnetic	resonance	imaging	(MRI)	and	computed	tomog‐
raphy	(CT),	have	been	used	to	monitor	changes	of	brain	size	and	
intracerebroventricular	 volumes	 in	 both	 human	 and	 ovine	 NCLs	
(Dyke	et	al.,	2016;	Jadav	et	al.,	2014;	Lobel	et	al.,	2013;	Sawiak	et	
al.,	2015;	Valavanis,	Friede,	Schubinger,	&	Hayek,	1980;	Woods	et	
al.,	1993).	Viral‐mediated	gene	therapy	trials	are	being	conducted	
in	affected	sheep	(Palmer,	2015).	In vivo assessment of brain atro‐
phy is integral to the longitudinal monitoring of individual animals 
and provides robust data for translation to human clinical trials.
It has been observed at postmortem	 examinations	 of	 NCL‐af‐
fected animals that their skulls are consistently thicker than those 
of	controls	and	that	the	intracranial	volume	(ICV)	reduces	with	dis‐
ease	 development,	 suggesting	 that	CT‐based	measurement	 of	 the	
ICV could be a suitable surrogate measure for brain size changes in 
ovine	NCL.	Determination	of	tissue	volumes	from	CT	data	requires	
discrimination	 of	 tissue	 boundaries.	 Tissues	 exhibit	 differences	 in	
their	ability	to	attenuate	radiation;	that	is,	they	have	differing	radio‐
densities.	The	CT	number	or	Hounsfield	unit	(HU)	provides	quanti‐
fication	of	the	extent	to	which	a	tissue	attenuates	X‐rays	(Table	1)	
(Hounsfield,	1980)	and	can	be	used	to	identify	boundaries	between	
adjacent	 tissues.	 Human	 brain	 HU	 values	 range	 between	 20	 and	
50,	and	those	of	cerebrospinal	fluid	(CSF)	vary	between	−5	and	20	
(Arimitsu,	Di	Chiro,	Brooks,	&	Smith,	1977;	Hacker	&	Artmann,	1978).	
Neurodegeneration	may	also	alter	the	radio‐density	of	brain	tissue,	
as	has	been	reported	in	sheep	and	dog	models	of	NCLs	(Armstrong,	
Quisling,	Webb,	&	Koppang,	1983;	Woods	et	al.,	1993).	The	aims	of	
this	study	were	to	determine	sheep‐specific	HU	thresholds	for	brain	
tissue	and	CSF,	to	investigate	the	relation	of	ICV	and	brain	volume	
in	NCL‐affected	animals	and	controls	and	to	perform	a	longitudinal	
study	of	ICV	and	brain	volumes	in	CLN5‐	and	CLN6‐affected	sheep	
and controls.
2  | MATERIAL S AND METHODS
All	 experiments	 were	 performed	 in	 accordance	 with	 the	 Lincoln	
University	Code	of	Ethical	Conduct	 for	 the	Use	of	Animals,	under	
the	New	Zealand	Animal	Welfare	Act	1999	and	were	approved	by	
the	 Lincoln	 University	 Animal	 Ethics	 Committee.	 Computed	 to‐
mography	 was	 conducted	 using	 a	 GE	 Prospeed	 CT	 scanner	 (GE	
Healthcare,	Hyogo,	Japan,	1997).
Previously performed CT scans of 56 sheep were analyzed to 
determine	 sheep‐specific	HU	 thresholds	 for	 brain	 tissue	 and	CSF.	
The sheep included both males and females aged between 3.6 and 
68.4 months and were CLN5+/- and CLN5−/−	 Borderdales,	 CLN6+/- 
CLN6−/−	 South	 Hampshires	 and	 unrelated	 control	 Coopworth	 and	
Romney	crosses.	HU	values	of	brain	(average	of	grey	and	white	mat‐
ter)	and	CSF‐filled	spaces	were	determined	using	ImageJ	(Rasband,	
ImageJ,	US	National	Institutes	of	Health,	Bethesda,	MD,	USA)	in	five	
images	selected	from	each	image	set	based	on	the	image	quality	and	
the	visibility	of	the	lateral	cerebral	ventricles.	The	average	HU	values	
of brain tissue were recorded from two 1‐cm2 circular areas selected 
for	their	visibility	and	uniformity	of	tissue	type	within	the	area,	and	
both	cortical	and	subcortical	areas	were	included.	Likewise,	a	1‐cm2 
circular area was selected within each of the lateral cerebral ventri‐
cles	and	the	average	HU	values	of	these	were	recorded.	Following	
this,	 the	99.9%	confidence	 intervals	 representing	 the	 range	of	HU	
values of brain tissue and CSF spaces were determined.
For the longitudinal investigations and the comparison of 
ICV	 and	 brain	 size,	 scan	 settings	were	 as	 follows:	 helical,	 120	kV,	
100	mA,	 1	mm	 slice	 thickness	 at	 a	 1‐mm	 slice	 interval	 and	 image	
analyses were performed in 3D Slicer 4.3.1 freeware (https://www.
slicer.org;	3D	Slicer:	RRID:SCR_005619)	(Fedorov	et	al.,	2012).	The	
ICVs were measured from the first image containing the olfactory 
bulbs to the final image containing cerebellum using the previously 
established	HU	threshold	for	both	brain	tissue	and	CSF	spaces,	‐12;	
56	(see	Section	3,	Figure	1)	using	the	“Editor”	tool.	The	volumes	of	
the third and lateral cerebral ventricles were measured using the 
previously	established	CSF	HU	 threshold	 (−12;	23).	The	 remaining	
CSF‐filled	spaces	(the	fourth	cerebral	ventricle,	cerebellar	aqueduct,	
TA B L E  1   Radio‐density of different body materials (Modified 
from	Hounsfield,	1980)
Hounsfield Units Material
−1,000 Air
−90	to	−70 Adipose
0 Water
20 to 60 Tissue (other than 
adipose	and	bone)
>500 Bone
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and	subarachnoid	spaces)	were	not	included	in	the	CSF	space	mea‐
surements because the resolution of the CT scans was insufficient 
for accurate discrimination between brain tissue and CSF in these 
regions. Threshold‐based selection of the areas was followed by 
manual correction for beam hardening and other scanning artefacts. 
The	 “MakeModelEffect”	 tool	 was	 used	 to	 produce	 three‐dimen‐
sional	(3D)	reconstruction	and	volumetric	measurements	of	the	re‐
gions of interest.
The	relationship	between	ICV	and	brain	volume	was	examined	
using	 severed	 heads	 from	 nine	 NCL‐affected	 male,	 two	 NCL‐af‐
fected	female,	and	14	unaffected	female	sheep	aged	8–69	months	
that were euthanized for other reasons than this study. Following 
exsanguination,	the	heads	were	CT	scanned	and	the	ICV	and	lateral	
cerebroventricular volumes measured using the protocols described 
above.	Following	CT	scanning,	the	skulls	and	meninges	were	opened	
dorsally	and	the	brains	removed,	leaving	the	pituitary	glands,	olfac‐
tory	bulbs,	and	the	dura	mater	behind.	The	spinal	cords	were	sev‐
ered transversely at a point perpendicular to the caudal margin of 
the	cerebellum.	Within	four	hours	of	collection,	brain	volumes	were	
measured	using	a	water	displacement	method.	A	horizontal	line	was	
drawn	on	the	outside	of	a	glass	beaker,	which	was	then	filled	with	
water	at	room	temperature	to	this	 line.	Next	a	brain	was	placed	in	
the	beaker,	which	caused	the	water	 level	to	rise	as	the	brain	sank.	
Water was removed until the water level was back to the initial line 
and the volume removed was recorded. The ratios of ICV to brain 
volume were calculated for both affected and normal sheep. The 
specific gravity of each brain was calculated by dividing the fresh 
brain	weight	by	the	water	displacement	volume,	and	the	effects	of	
disease	status	on	ICV,	brain‐specific	gravity,	and	ratio	of	ICV	to	brain	
volume were investigated.
All	observations	indicate	that	the	neuropathology	in	ovine	CLN5	
Batten disease is independent of gender and sheep of all genders 
(rams,	ewes,	and	wethers)	were	used.	The	longitudinal	investigations	
included	a	total	of	24	animals,	12	animals	born	in	2014	(six	affected	
males,	six	female	controls),	and	12	born	in	2015	(six	affected	females,	
six	 female	 controls).	 Each	 group	 of	 12	 contained	 CLN6−/− (n	=	3)	
and CLN6+/- (n	=	3)	South	Hampshire	sheep	and	CLN5−/− (n	=	3)	and	
CLN5+/- (n	=	3)	Borderdale	sheep.	All	heterozygous	sheep	(i.e.,	CLN5+/- 
and CLN6+/-)	 were	 clinically	 normal	 and	 served	 as	 control	 animals.	
The sheep were aged between 3 and 5.8 months when first scanned 
and	scans	were	performed	bimonthly	until	an	age	of	15–19	months,	
depending on the clinical condition of individuals. They were kept 
outdoors	on	pasture.	Prior	to	each	CT	scan,	the	sheep	were	fasted	
for	18–24	hr	and	then	weighed.	On	the	day	of	CT	scanning,	the	sheep	
were	anaesthetized	by	intravenous	injection	of	a	mixture	of	0.8	mg/
kg	 live	 weight	 (LW)	 diazepam	 (Pamlin	 injection,	 Troy	 Laboratories	
NZ	 Pty	 Ltd,	 Auckland,	 New	 Zealand)	 and	 17	mg/kg	 LW	 of	 ket‐
amine	 hydrochloride	 (Phoenix	 Ketamine	 injection,	 Phoenix	 Pharm	
Distributors	 Ltd,	 Auckland,	 New	 Zealand).	 They	were	 then	 placed	
on	a	wooden	stretcher	in	dorsal	recumbency,	and	the	stretcher	was	
loaded onto the CT scanner. The heads were scanned following the 
protocol	described	above.	After	scanning,	the	sheep	were	taken	to	
a padded wake‐up area and remained under observation until they 
recovered,	when	they	were	returned	to	their	corresponding	flocks.
For	 statistical	 analysis	 of	 the	 longitudinal	 data,	 animals	 were	
grouped by breed and genotype (CLN5+/-, CLN5−/−, CLN6+/-, CLN6−/−)	
and	the	repeated	measurements	were	allocated	into	age‐groups	(3,	
5,	 7,	 9,	 11,	 13,	 15,	 17,	 and	 19	months).	Means	 and	 corresponding	
standard errors of the mean (SEM)	were	calculated	for	ICV	and	ven‐
tricular volumes at each age for each group of animals. The change 
in	ICV	was	calculated	for	each	animal	for	each	period	(3–5	months,	
5–7	months,	etc.),	and	the	mean	accumulative	ICV	gain	or	loss	(from	
3	to	19	months)	was	determined	for	each	genotype.	Data	process‐
ing	and	statistical	analyses	were	performed	in	Microsoft	Excel	2016	
(Microsoft	 Corp.,	 Seattle,	 WA,	 USA)	 and	 GenStat	 for	 Windows	
16th	 Edition	 (RRID:SCR_014595,	 VSN	 International	 2011,	 Hemel	
Hempstead,	 UK).	 Student’s	 t tests were performed for pairwise 
comparisons	 of	 affected	 and	 normal	 (control)	 animals.	 Repeated	
ANOVAs	were	performed	on	longitudinal	data.	Results	are	reported	
as means ± SEM. Differences are regarded significant where p < 0.05.
3  | RESULTS
The	mean	 brain	 tissue	 HU	 value	 including	 both	 affected	 and	 un‐
affected	 animals	 after	 exsanguination	 was	 39.5	 with	 a	 stand‐
ard	 deviation	 of	 5.2,	 and	 thus,	 99.9%	 of	 the	 ovine	 brain	 tissue	
was	 represented	 by	 the	 HU	 interval	 (24;	 56).	 Likewise,	 99.9%	 of	
CSF	 spaces	was	 represented	 in	 the	HU	value	 interval	of	 (−12;	23;	
Figure	1).	The	mean	radio‐density	(HU	value)	of	brain	tissue	in	NCL‐
affected animals (n	=	42)	was	greater	than	that	of	brain	tissue	from	
F I G U R E  1   Range of radio‐densities representing ovine brain 
tissue	and	CSF.	Normal	distribution	of	the	Hounsfield	units	(HU)	
representing	the	radio‐densities	of	ovine	brain	tissue	(HU	range	of	
brain	tissue)	and	those	of	ovine	cerebrospinal	fluid	(HU	range	of	
CSF)	(n	=	72).	Mean	HU	of	brain	tissue	=	739.7;	SD	=	75.3;	99.9%	
confidence	interval	(24;	56).	Mean	HU	of	CSF	=	75.6;	SD	=	75.8;	
99.9%	confidence	interval	(−12;	23)
-2
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unaffected controls (n	=	14)	(mean	affected	=	40.3	±	0.3;	mean	con‐
trol = 38.4 ± 0.8; p	=	0.037).	 There	 was	 no	 such	 difference	 in	 the	
radio‐density of CSF‐filled spaces (mean affected = 5.6 ± 0.5; mean 
control = 5.5 ± 0.6; p = 0.8).
Brain volumes measured after post mortem by water displace‐
ment,	 and	 the	 corresponding	 ICVs	measured	 from	CT	 scans	were	
both	lower	for	NCL‐affected	animals	than	those	of	controls	(Table	2).	
Both CT scan ICVs and brain volumes of unaffected control animals 
closely	matched,	but	the	ICVs	of	NCL‐affected	animals	measured	by	
CT	scanning	were	approximately	4	ml	larger	than	the	corresponding	
brain	volumes	measured	by	displacement.	Based	on	this,	the	ratio	of	
ICV	to	brain	volume	was	 larger	 in	NCL‐affected	animals	compared	
with unaffected controls. Disease status had no effect on the spe‐
cific	gravity	of	the	brain	(Table	2).
The CT‐based 3D reconstructions of the ICV of both CLN5−/− 
and CLN6−/− animals showed obvious visible changes compared 
with	controls	 (Figure	2).	By	7	months	of	age,	 the	affected	 ICVs	of	
both affected genotypes were smaller than those of age‐matched 
controls.	At	17	months,	the	regionality	of	the	brain	atrophy	was	re‐
flected in the shape of the ICVs. Whereas the cerebellar area of the 
ICVs	was	largely	unchanged,	the	cerebral	cortical	areas	appeared	to	
be	 considerably	 thinner	 than	 those	 of	 controls,	 particularly	 in	 the	
occipital	 region	 (Figure	2,	https://www.tinkercad.com/things/1dlX‐
ELC0gvp‐sheep‐brain‐cavity‐19mth‐control,	 https://www.
tinkercad.com/things/5Y1f9AKrEiA‐sheep‐brain‐cavity‐19mth‐bat‐
ten‐disease).	Overall,	 ICVs	 from	17‐month‐old	 affected	 animals	 of	
both	genotypes	were	smaller	than	those	of	controls,	and	also	smaller	
than	that	they	were	at	7	months	of	age.
The progression of changes in ICVs of Borderdale (CLN5−/− and 
CLN5+/‐)	 sheep	 is	 summarized	 in	 Figure	 3.	 By	 3	months,	 the	mean	
ICV of CLN5−/− sheep was smaller than that of unaffected age‐ and 
breed‐matched controls. This difference became statistically signif‐
icant by 5 months and remained so until the end of the trial period 
at 19 months. The accumulative change of ICV in CLN5+/- control 
animals	initially	increased	between	3	and	5	months,	then	remained	
steady	 until	 approximately	 9	months,	 followed	 by	 another	 growth	
phase until leveling off from about 15 months of age. The mean 
ICV of CLN5−/− sheep initially increased between the ages of 3 and 
5	months,	 similarly	 to	 that	of	 controls.	Thereafter,	 the	volume	de‐
creased,	plateaued	between	7	and	11	months,	and	then	decreased	
rapidly	until	 the	end	of	 the	 trial	period	at	19	months.	On	average,	
CLN5−/−	sheep (n	=	6)	lost	a	total	ICV	of	6.7	±	2.6	ml	between	3	and	
17	months,	whereas	the	mean	ICV	of	control	sheep	(n	=	6)	increased	
by	2.7	±	1.6	ml	over	that	period.
Changes	 in	 the	 ICVs	 of	 South	 Hampshire	 sheep	 (CLN6−/− and 
CLN6+/-)	 are	 summarized	 in	 Figure	 4.	 The	 accumulative	 change	 of	
ICV in CLN6+/- control animals was similar to that of the CLN5+/-
	 control	 animals.	A	 slow	phase	of	 ICV	gain	occurred	until	 the	 age	
of	approximately	10	months,	 followed	by	a	short	steep	 increase	 in	
ICV	until	approximately	15	months	of	age,	when	the	ICV	plateaued.	
The accumulative change of ICV in CLN6−/− animals was similar to 
changes in the CLN5−/−	animals.	An	initial	increase	was	followed	by	a	
slight	decline	between	5	and	7	months,	a	plateau	until	approximately	
10 months of age and then volumes declined rapidly until the end of 
the	trial	period	at	17	months.	A	total	mean	ICV	loss	of	5.8	±	2.5	ml	
occurred in CLN6−/−	sheep (n	=	6)	between	3	and	17	months,	while	
controls (n	=	6)	 gained	3.8	±	1.2	ml	 ICV	on	 average	over	 the	 same	
period.
The mean volumes of the lateral and third cerebral ventricles are 
summarized in Figure 5. Those of CLN5−/− animals were significantly 
larger	than	those	of	controls	throughout	the	entire	trial	period,	and	
although the mean ventricular volumes of CLN6−/− animals tended 
to	be	higher	than	those	of	controls,	this	did	not	become	statistically	
significant	until	17	months	of	age.
4  | DISCUSSION
Neuroimaging	has	been	a	component	of	disease	monitoring	in	NCL	
research	for	some	time	but,	until	recently,	the	methods	were	basic	
and mainly focused on time‐point analyses rather than longitudinal 
monitoring of individuals. This study sets out to investigate the im‐
provements that could be achieved through automated methods of 
image analysis to establish the relationship between the reduction 
in	ICV	and	brain	atrophy,	and	describe	the	patterns	of	ICV	change	
in	CLN5‐affected	Borderdale,	CLN6‐affected	South	Hampshire,	and	
unaffected control sheep.
Measurements of radio‐densities of brain tissue and CSF spaces 
in	 NCL‐affected	 sheep	 and	 unaffected	 controls	 led	 to	 improved	
image	analysis.	An	increased	radio‐density	of	brain	tissue,	measured	
in	HU,	was	 observed	 in	 affected	 animals	 compared	with	 controls.	
This	has	also	been	described	in	other	models	(ovine	and	canine)	of	
Measurement
Affected 
(mean ± SEM)
Control 
(mean ± SEM) p
ICV	(ml) 80.5	(±	2.3) 99.9	(±	1.7) <0.001
Volume	(ml) 76.5	(±	2.1) 101.1	(±	1.7) <0.001
ICV:Volume ratio 1.06	(±	0.02) 0.99	(±	0.01) 0.03
Specific gravity of brain tissue 
(g/cm3)
0.98	(±	0.2) 1.01	(±	0.01) 0.11
Note.	 Volumetric	 brain	 measurements	 of	 NCL‐affected	 (n	=	11)	 and	 unaffected	 control	 (n	=	14)	
sheep.	Intracranial	volumes	(ICV)	measured	on	CT	scans	and	brain	volumes	(Volume)	measured	by	
water displacement. p	≤	0.05	regarded	as	significant.
TA B L E  2   Brain and intracranial volume 
comparisons
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NCL	(Armstrong	et	al.,	1983;	Woods	et	al.,	1993).	The	specific	grav‐
ity of brains from affected animals was not increased even though 
the	brains	of	affected	sheep	have	been	described	as	firmer	in	texture	
than	 those	of	 controls	 (Jolly	et	al.,	1989).	The	 range	of	HU	values	
representing brain tissue and CSF spaces reported here are in close 
agreement	 with	 findings	 from	 similar	 investigations	 in	 humans,	
where	the	mean	HU	value	of	grey	matter	was	39,	that	of	white	mat‐
ter	32	and	that	of	CSF	ranged	between	−5	and	20	(Arimitsu	et	al.,	
1977;	Hacker	&	Artmann,	1978).	The	present	results	have	enabled	
semi‐automated analyses of CT scans to be used for longitudinal 
monitoring	of	treatment	trials	in	NCL	sheep	and	to	create	3D	images.
The comparison between CT‐based volumetric measurements 
of the cranial vault and brain volume measured by water displace‐
ment confirms the validity of the CT measurements as a surrogate 
for brain volume. The ratio of ICV to brain volume in normal sheep 
was	close	to	unity.	However,	the	ratio	for	NCL‐affected	animals	was	
1.06,	which	is	larger	(p = 0.03)	than	that	of	normal	sheep	and	shows	a	
slight discrepancy between the ICV and brain volume measurements 
recorded	here.	The	reduction	in	ICV	in	NCL‐affected	animals	and	the	
3D reconstruction thereof presented in this study support the the‐
ory	of	an	ongoing	ossification	of	the	skull	in	these	animals.	However,	
the larger ratio of ICV to brain volume indicates that the brain at‐
rophy	precedes	this	ossification,	suggesting	that	the	ossification	 is	
not	causative	of	brain	atrophy,	but	is	rather	a	symptom	of	it.	This	is	
in agreement with an increase in space between the atrophied brain 
and the cranial vault of CLN6−/−	NCL‐affected	sheep	reported	earlier	
(Cook	et	al.,	2002).
In	human	NCLs	and	other	forms	of	dementia,	remodeling	of	the	
skull is unusual and is mainly seen in diseases that also affect other 
parts	of	the	skeleton,	such	as	mucopolysaccharidosis	and	other	skel‐
etal	dysplasias	 (Jelin	et	 al.,	2017).	However,	 thickening	of	 the	cra‐
nium,	 also	 called	 hyperostosis	 cranii	 ex vacuo,	 has	 been	 described	
in	 hydrocephalic	 children	 sporadically,	 usually	 as	 a	 side	 effect	 of	
successful	ventricular	shunting,	and	as	a	rare	consequence	of	brain	
atrophy	 (Di	 Preta,	 Powers,	&	Hicks,	 1994;	Wolf	&	 Falsetti,	 2001).	
More	detailed	investigations	into	the	molecular	mechanism,	and	the	
regional changes are needed to understand the dynamics of ICV 
changes	in	ovine	NCL	as	well	as	in	other	species.	The	present	ovine	
NCL	models	provide	an	excellent	platform	from	which	to	investigate	
this phenomenon longitudinally.
Although	 it	has	been	 long	established	that	CLN5‐	and	CLN6‐	
affected	 sheep	 exhibit	 a	 reduction	 in	 brain	 size	 (Jolly	 &	 West,	
1976;	Jolly	et	al.,	2002;	Jolly,	Janmaat,	Graydon,	&	Clemett,	1982),	
longitudinal	 monitoring	 is	 required	 to	 describe	 the	 rate	 of	 this	
change.	As	brain	size	 is	 related	 to	overall	body	size	 (Courchesne	
et	 al.,	 2000;	 Ebinger,	 1974;	 Edland	 et	 al.,	 2002),	 large	 individual	
variation	 would	 be	 expected	 in	 the	 measurements	 of	 ICV,	 and	
this	might	overshadow	disease	effects.	Assessment	of	the	rate	of	
change	instead	of	actual	volumes	(Figures	3	and	4)	yields	a	better	
understanding of disease mechanisms by accounting for the con‐
founding effects of body size and weight. This becomes particu‐
larly	clear	when	comparing	the	mean	ICV	data	of	CLN5	Borderdale	
and	 CLN6	 South	 Hampshire	 sheep,	 which	 are	 two	 breeds	 that	
differ	 in	both	build	and	size.	 In	 this	study,	CLN5−/− animals could 
easily be distinguished from CLN5+/- animals based on ICV at three 
months	(Figure	3).	This	was	not	possible	in	CLN6	animals	until	the	
F I G U R E  2   Representative 3D models of cranial volumes of 
a	CLN5	and	a	CLN6	affected	sheep	and	a	control.	Computer	
tomography	(CT)‐based	three‐dimensional	(3D)	modelling	of	
intracranial	volumes	(ICV).	In	both	CLN5−/− and CLN6−/−,	the	loss	
of	ICV	and	enlargement	of	lateral	cerebral	ventricles	(blue)	were	
evident	at	7	months	of	age	and	were	pronounced	at	17	months	
compared with the healthy control. The top row of each block 
shows	the	dorsal	view,	the	middle	row	shows	the	semi‐opaque	
dorsal	view	so	that	the	lateral	ventricles	are	visible,	and	the	bottom	
row shows the lateral view
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very	 end	 of	 the	 trial	 period,	 as	 the	mean	 ICV	 of	CLN6‐affected	
animals	remained	similar	to	that	of	controls	for	 longer	(Figure	4).	
However,	 the	patterns	of	 ICV	change	 in	different	genotypes	be‐
came obvious when analyzing the accumulative change instead of 
the	mean	volume.	With	this,	it	is	possible	to	distinguish	between	
affected	animals	 and	controls	 from	a	young	age.	For	both	CLN5	
and	 CLN6	 sheep,	 the	 present	 study	 showed	 that	 the	 ICV	 of	 af‐
fected	animals	changed	only	minimally	until	the	approximate	age	
of	10	months,	which	can	be	described	as	an	absence	of	gain	rather	
than	an	active	 loss,	while	 the	 ICV	of	control	animals	 steadily	 in‐
creased	 throughout	 the	 same	 period.	 After	 this,	 the	 ICV	 was	
reduced in both CLN5−/− and CLN6−/−	 animals,	 while	 the	 ICV	 of	
control animals plateaued. The 3D reconstructions revealed that 
the ICV changes follow the regionality of neuropathology that has 
been	previously	described	 (Oswald	et	al.,	2005;	Oswald,	Palmer,	
Kay,	Barwell,	&	Cooper,	2008).
F I G U R E  3   Development of intracranial 
volume	(ICV)	in	CLN5	sheep.	ICV	
development of CLN5−/− and CLN5+/-
	sheep	between	3	and	19	months	(mo).	
(a)	Mean	ICV	±SEM	at	different	ages	(*	
indicating significance at p	≤	0.05).	(b)	
Mean accumulative ICV gain or loss (± 
SEM,	dotted	lines)	from	3	mo	of	age.	
CLN5+/-: 3 mo n = 3;	5–17	mo	n = 6; 19 mo 
n = 3. CLN5−/−: 3 mo n	=	3;	5–17	mo	n = 6; 
19 mo n = 2
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F I G U R E  4   Development of intracranial 
volume	(ICV)	in	CLN6	sheep.	ICV	
development of CLN6−/− and CLN6+/- sheep 
between	3	and	19	months	(mo).	(a)	Mean	
ICV	±SEM	at	different	ages.	(b)	Mean	
accumulative ICV gain or loss (± SEM,	
dotted	lines)	from	3	mo	of	age.	CLN6+/-: 
3 mo n = 3;	5–17	mo	n = 6. CLN6−/−: 3 mo 
n	=	3;	5–17	mo	n = 6
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F I G U R E  5  Cerebral	ventricular	volumes	of	CLN5	and	CLN6	sheep.	Volumes	of	intracerebral	ventricles	(lateral	and	third	ventricles	
combined)	of	CLN5−/− and CLN6−/−	animals	and	heterozygous	controls	at	different	ages	(months,	mo).	(a)	Mean	ventricular	volumes	(±	SEM)	
of CLN5−/− and CLN5+/-	animals.	(b)	Mean	ventricular	volumes	(±	SEM)	of CLN6−/− and CLN6+/-	animals.	Significance	indicated	with	*	where	
p	≤	0.05,	Student's	t test. CLN5+/-: 3 mo n = 3;	5–17	mo	n = 6; 19 mo n = 3. CLN5−/−: 3 mo n	=	3;	5–17	mo	n = 6; 19 mo n = 2. CLN6+/-: 3 mo 
n = 3;	5–17	mo n = 6; CLN6−/−: 3 mo n	=	3;	5–17	mo	n = 6
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The volumes of the third and lateral ventricles of all four genotypes 
were relatively stable throughout the entire study period. The third and 
lateral ventricular volumes of CLN5−/− animals were larger than those 
of controls and a lesser similar trend was observed in CLN6−/−	animals,	
which did not become significant until the very end of the trial period 
(Figure	3).	Overall,	ventricular	enlargement	was	more	pronounced	in	
CLN5−/− animals than in CLN6−/−	animals,	which	may	indicate	a	differing	
pattern	of	brain	atrophy	in	the	different	types	of	ovine	NCL.	In	recent	
past,	 a	 high‐resolution	 sheep	 brain	MRI	 atlas	 has	 been	 established	
based on the brains of 18 sheep and it showed that the mean volume of 
the	lateral	and	third	ventricles	combined	was	approximately	4.9	ml	(Ella	
&	Keller,	2015;	Ella,	Delgadillo,	Chemineau,	&	Keller,	2017).	The	dis‐
crepancy between these measures and the measures recorded in the 
present	study	is	likely	consequent	to	differences	in	the	measurement	
techniques	and	 issues	with	 the	 spatial	 resolution	of	 the	CT	 scanner	
used,	and	 the	present	measures	 reflect	 the	ventricular	volumes	suf‐
ficiently to compare affected and normal sheep within the same trial.
This study was limited by the age of the CT scanner available to 
the	project,	which	has	 an	 inferior	 resolution	 compared	with	mod‐
ern machines. The low resolution was insufficient to accurately 
discriminate	 tissue	 borders	 for	 small	 CSF‐filled	 spaces,	 leading	 to	
varying measures of the ventricular volumes in this study. Newer 
CT scanners would overcome this problem and enable more detailed 
measures	of	the	CSF	space,	including	the	4th	ventricle	and	the	sub‐
arachnoid space. The use of MRI instead of CT would increase the 
resolution	 and	 discrimination	 of	 soft	 tissue	 boundaries.	 However,	
the availability of MRI for large animal model research is limited by 
costs and lack of animal MRI facilities leading to logistical issues as 
well as longer scan times involving an increased need for anaesthe‐
sia.	CT	scanning,	on	the	other	hand,	is	much	faster	than	MRI	and	in	
the present situation was easily available on‐site.
The present results show that CT‐based measurements of the 
intracranial volumes yield robust longitudinal information for the in 
vivo	monitoring	of	ovine	NCL.	The	findings	of	this	study	are	signif‐
icant	as	 the	 techniques	developed	here	 for	 repeated,	noninvasive,	
measures are already being used as valuable tools for the assess‐
ment of disease progression in trials of potential new therapies for 
the	treatment	of	human	NCL	(Mitchell	et	al.,	2018).
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